US CLARITY Act Could Reshape Crypto Regulations in Eastern Financial Hubs SP 500 and Nasdaq Hit Record Closing Highs WTI Crude Declines on Iran Peace Deal Optimism Estate Planning Strategies for HighIncome Trusts Shifting Tax Burden to Beneficiaries EU Prepares Landmark Fine Against Alphabets Google Over Digital Markets Act Violations Money Market Account Rates TopYielding Accounts Offer 401 APY as of May 24 2026 Hormel Foods Joins HighYield Retirement Income Stocks Amid Analyst Price Target Revisions AIG Q1 2026 Earnings Strong EPS Surprise Amidst Steady Operational Execution Aterian Inc ATER Q3 2025 Earnings Strong EPS Beat Highlights Operational Efficiency TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress Saratoga Investment Corp SAR Q1 2026 Earnings EPS Turns Negative Missing Estimates by a Wide Margin PENN Q1 2026 Earnings EPS Misses Estimates as Company Reports Adjusted Loss REVB Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges Camtek CAMT Pulls Back 29 as Shares Test Key Support Zone Near 161 UroGen Pharma URGN Advances 197 Approaching Key Resistance at 3093 JM Smucker SJM Rallies 175 as Shares Test Key Resistance Zone Sabine Royalty Trust SBR Holds Steady Near MidRange as Energy Royalty Sector Consolidates Stellus Capital Investment SCM Gains 167 as Shares Approach Key Resistance 960 Level in Focus Prediction Markets Surge as a MultiBillionDollar Industry Attracting Young Male Demographic MIRA Pharmaceuticals Q3 2025 Earnings EPS Beats Estimates Amid Narrowing Losses Stock Declines AgomAb Therapeutics AGMB Advances 317 as Biotech Stock Nears Key Resistance ATS Q1 2026 Earnings EPS Surpasses Estimates by 924 Stock Rises 391 CGBD Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Nephros Q1 2026 Earnings EPS Misses Estimates by a Hair Shares Edge Higher Carlyle Credit Income Fund CCID Q1 2026 Earnings EPS Misses Estimates by 317 Shares Edge Lower REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4 High Tide Inc Q1 2026 Earnings Profitability Surprise as EPS Beats Estimates by 300 Quantum Biopharma Ltd QNTM Q4 2025 Earnings Net Loss Deepens as PreRevenue Stock Sheds 237